The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: Results from the German Transcatheter Aortic Valve Interventions Registry

American Heart Journal

Volumn 164, Issue 1, 2012, Pages

  Sinning, Jan Malte ^a   Horack, Martin ^b   Grube, Eberhard ^a,c   Gerckens, Ulrich ^c,d   Erbel, Raimund ^e   Eggebrecht, Holger ^e,f   Zahn, Ralf ^g   Linke, Axel ^h   Sievert, Horst ⁱ   Figulla, Hans Reiner ^j   Kuck, Karl Heinz ^k   Hauptmann, Karl Eugen ^l   Hoffmann, Ellen ^m   Hambrecht, Rainer ⁿ   Richardt, Gert ^o   Sack, Stefan ^p   Senges, Jochen ^b   Nickenig, Georg ^a   Werner, Nikos ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Institut fuer Herzinfarktforschung   (Germany)

^c Department of Pediatrics Helios Klinikum   (Germany)

^d Gemeinschaftskrankenhaus St Petrus GGmbH   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^g KLINIKUM LUDWIGSHAFEN   (Germany)

^h UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

ⁱ Katharinen Krankenhaus   (Germany)

^j JENA UNIVERSITY HOSPITAL   (Germany)

^k DEPARTMENT OF CARDIOLOGY   (Germany)

^l KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^m Uroclinic Bogenhausen   (Germany)

ⁿ Herzzentrum   (Germany)

^o Segeberger Kliniken   (Germany)

^p Klinikum Schwabing   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SURGICAL APPROACH; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

EID: 84863724236     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.04.016     Document Type: Article

References (25)

1. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187-98.
2. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106: 3006-8. (Pubitemid 35440280)
4. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616-24. (Pubitemid 44547432)
5. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
6. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
7. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010;31: 1398-403.
8. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
9. Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011;32:148-57.
10. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
11. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: results from a multi-centre real-world registry. Eur Heart J 2011;32:198-204.
12. Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 2010; 5:666-72.
13. Tchetche D, Dumonteil N, Sauguet A, et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention 2010;5: 659-65.
14. Van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 2010; 5:673-9.
15. Kahlert P, Al-Rashid F, Weber M, et al. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz 2009;34:398-408.
16. Aronow WS. Peripheral arterial disease in the elderly. Clin Interv Aging 2007;2:645-54.
17. Saw J, Bhatt DL, Moliterno DJ, et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol 2006;48:1567-72. (Pubitemid 44528177)
18. Singh M, Lennon RJ, Darbar D, et al. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. Mayo Clin Proc 2004;79: 1113-8. (Pubitemid 39129472)
19. Sinning JM, Ghanem A, Steinhauser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010;3:1141-9.
20. Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009;2:811-20.
21. Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009;120:2053-61.
22. Nikolsky E, Mehran R, Mintz GS, et al. Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions. J Endovasc Ther 2004;11: 60-70. (Pubitemid 38197616)
23. Delgado V, Ewe SH, Ng AC, et al. Multimodality imaging in transcatheter aortic valve implantation: key steps to assess procedural feasibility. EuroIntervention 2010;6:643-52.
24. Di Mario C, Alfieri O, Iung B, Serruys PW. Transcatheter valves and interventional cardiology. EuroIntervention 2011;6:673-7.
25. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-69.